Momentum Group Ltd and Bonheur 94 General Trading (Pty) Ltd (84/LM/Oct04) [2005] ZACT 37 (2 June 2005)

Momentum Group Ltd and Bonheur 94 General Trading (Pty) Ltd (84/LM/Oct04) [2005] ZACT 37 (2 June 2005)

The Tribunal found that the restructuring of the transaction, resulting in Momentum acquiring full control of Bonheur and Sovereign Health, eliminated the risk of anti-competitive information sharing between competitors. The market for medical scheme administration is characterized by numerous competitors, strong countervailing power from scheme trustees, and low barriers to entry. The combined market share of the First Rand Group post-merger would be 28%, but this does not raise significant competition concerns given the competitive dynamics and ease of entry. The merger is unlikely to substantially prevent or lessen competition. No public interest concerns, such as retrenchments, were...

Citation
[2005] ZACT 37
Parties
Applicant: Momentum Group Ltd; Respondent: Bonheur 94 General Trading (Pty) Ltd
Court
Competition Tribunal
Jurisdiction
South Africa
Judgment Date
2 June 2005
Case Number
84/LM/Oct04
Procedural Posture
Large Merger Review / Merger Approval
Outcome
Merger approved subject to the transaction being as reflected in the specified agreements.
Judges
N Manoim, D Lewis, Y Carrim
Legal Topics
Large Merger Review, Market Share Analysis, Information Sharing Concerns, Countervailing Power, Barriers to Entry
Competition Law Commercial and Corporate Large Merger Review Market Share Analysis Information Sharing Concerns Countervailing Power Barriers to Entry

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 3 Authorities cited 2 Party arguments 2 Amounts and remedies 4
Sign in to unlock

Parties

Momentum Group Ltd

Applicant

Bonheur 94 General Trading (Pty) Ltd

Respondent

Procedural Posture

Large Merger Review / Merger Approval

Legal Issues

  1. 1 Whether the proposed merger would substantially prevent or lessen competition in the market for medical scheme administration.
  2. 2 Whether the structural links between Momentum, Discovery, and Medscheme could facilitate anti-competitive information sharing.
  3. 3 Whether public interest concerns, such as retrenchments, arise from the merger.

Ratio Decidendi

The Tribunal found that the restructuring of the transaction, resulting in Momentum acquiring full control of Bonheur and Sovereign Health, eliminated the risk of anti-competitive information sharing between competitors. The market for medical scheme administration is characterized by numerous competitors, strong countervailing power from scheme trustees, and low barriers to entry. The combined market share of the First Rand Group post-merger would be 28%, but this does not raise significant competition concerns given the competitive dynamics and ease of entry. The merger is unlikely to substantially prevent or lessen competition. No public interest concerns, such as retrenchments, were...

Court Disposition

Merger approved subject to the transaction being as reflected in the specified agreements.

Orders

  • The merger between Momentum Group Ltd and Bonheur 94 General Trading (Pty) Ltd is approved, provided the transaction is as reflected in the Sale of Business Agreement and Sale of Shares Agreement dated 25 April 2005.
  • No retrenchments are anticipated as a result of the merger.